France· FR:69558317
ADVATE 3000 UI, poudre et solvant pour solution injectable
A octocog alfa product, registered in France by TAKEDA MANUFACTURING AUSTRIA (AUTRICHE). The same ATC class is registered in 3 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Octocog alfa is registered in 3 of 19 countries.
Countries holding a registration under ATC B02BD28 (octocog alfa), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 1 of them publish a price we can compare per daily dose
Octocog alfa · ATC B02BD28
3 / 19 countries
- Franceprice
- Germany
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Manufacturer
- TAKEDA MANUFACTURING AUSTRIA (AUTRICHE)
- Country
- France (FR)
- ATC code
- B02BD28
- ATC class
- Octocog alfa
- Defined daily dose
- 1 TSD, E
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009587210141 flacon(s) en verre de 3000 UI - 1 flacon(s) en verre de 5 ml avec dispositif BAXJECTIII
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for octocog alfa.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Octocog alfa · interactions on record
4 records
- 2 severe
- 2 moderate
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- PegvaliaseA16AB19moderate
- EmicizumabB02BX06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Octocog alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAdvate 3000 IU, poeder en oplosmiddel voor oplossing voor injectie 600 IU_mlTakeda Manufacturing Austria AG
- BelgiumAdvate 1000 IUTakeda Austria
- CzechiaADVATETakeda Manufacturing Austria AG, Vídeň
- SpainADVATE 1.000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLETakeda Manufacturing Austria Ag
- FinlandAdvateAbacus Medicine A/S
- United KingdomAdvate 1,000unit powder and solvent for solution for injection vialsTakeda UK Ltd
- IrelandAdvate 1000 IU/2 ml powder and solvent for solution for injectionTakeda Manufacturing Austria AG
- ItalyADVATE*1 flaconcino EV 1.000 Unita' Internazionali + 1 flaconcino solv 2 ml preassemblati con dispositivo per ricostituzioneTAKEDA MANUFACTURING AUS. AG
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Germany · Recombinate
- Iceland · Advate, Kovaltry
- Italy · Recombinate
- Liechtenstein · Advate, Kovaltry
- Lithuania · Recombinate
- Netherlands · Recombinate
- Norway · Advate, Kovaltry
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bac1b7d4-5105-4dba-9046-ae0d56cdcb98 GET /v1/drugs/bac1b7d4-5105-4dba-9046-ae0d56cdcb98?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69558317",
"date_amm": "2008-05-22",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/03/271",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about octocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.